Articles tagged "Immunosuppression"

2015 American Transplant Congress
Inadequate Overall Immunosuppression Is a Risk for Late Acute Rejection Despite Alemtuzumab Induction in Simultaneous Pancreas Kidney Transplant Recipients
J. Bank,¹ M. Mallat,¹ P. van der Boog,¹ D. Braat,² J. Ringers,² M. Vergunst,³ S. Heidt,³ F. Claas,³ M. Reinders,¹ J. de Fijter.¹
¹Nephrology, LUMC, Leiden, Netherlands; ²Surgery, LUMC, Leiden, Netherlands; ³IHB, LUMC, Leiden, Netherlands.
Introduction: Simultaneous pancreas-kidney transplantation (SPK) has become the treatment of choice for patients with end-stage renal disease due to Type 1 Diabetes Mellitus. SPK is…
2015 American Transplant Congress
Pregnancy Outcomes in Solid Organ Transplant Recipients With Exposure to Sirolimus Without Mycophenolate
N. Sifontis,¹ L. Coscia,² D. Armenti,² S. Constantinescu,^2,3 M. Moritz.^2,4
¹Pharmacy Practice, Temple University, Philadelphia; ²National Transplantation Pregnancy Registry, Gift of Life Institute, Philadelphia; ³Temple University School of Medicine, Philadelphia; ⁴Lehigh Valley Health Network, Allentown.
Results of prior sirolimus series reports have been confounded by concomitant mycophenolate exposure. The purpose of this study was to describe pregnancy outcomes with exposure…
2015 American Transplant Congress
Everolimus Plus Reduced-Exposure Calcineurin Inhibitor Versus Mycophenolate Mofetil Plus Standard-Exposure Calcineurin Inhibitor: 2-Year Results in Living Donor Kidney Transplant Recipients
Y. Watarai,¹ N. Akutsu,² K. Saito,³ Y. Nakagawa,³ O. Kamisawa,⁴ T. Kenmochi.⁵
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan; ²Surgery, Chiba-East Hospital, Chiba, Japan; ³Urology, Niigata University, Niigata, Japan; ⁴Medical Division, Novartis Pharma K.K., Tokyo, Japan; ⁵Transplant Surgery, Fujita Health University, Toyoake, Japan.
Purpose: To evaluate the long-term efficacy and safety of everolimus (EVR) plus reduced cyclosporine (rCsA) compared to mycophenolate mofetil (MMF) plus standard cyclosporine at 24…
2015 American Transplant Congress
Eosinophilic Gastrointestinal Disease in Pediatric Liver and Kidney Transplant Recipients
S. Mohammad,¹ J. Bush,² K. Amsden,¹ A. Kagalwalla,¹ H. Melin-Aldana,² N. Arva.²
¹Pediatrics, Northwestern University, Chicago; ²Pathology, Northwestern University, Chicago.
Eosinophilic gastrointestinal disease (EGID) has been associated with immunosuppression use in solid organ transplant recipients. However, its relationship to the post-transplant clinical course is unknown.…